Rifampin
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type.
United States
$30
per month
India
$3
per month
You save
−89%save $26/mo · 89% cheaper
112K US scripts/yr$3M potential annual savings$3.3M US spend/yr
Drag to rotate · 3D structureC43H58N4O12
SMILES: C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
Compare the price
US price$30per month
India price$3per month
You save$2689% less
Based on 30 units per month. US $0.98 vs India $0.11 per unit.
Total over 1 periodSave $26$30 → $3
The bigger picture
Rifampin is filled about 112K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$3.3M
If sourced from India
$352.7K
Potential annual savings
$3M
−89%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.